Belgium's Ministry of Health has paused dosing of people under the age of 41 with Johnson & Johnson's one-shot COVID-19 vaccine, following the death of a woman from what appeared to be
Moderna's COVID-19 vaccine has joined the Pfizer/BioNTech jab in showing efficacy in younger patients in clinical trials, setting up an emergency use filing early next month.
After decades of struggling with poor public perception, the pharma industry has an opportunity to generate stronger connections with consumers than ever thanks to the COVID-19 vaccine driv
As US and EU health regulators review cases of heart inflammation seen in young people administered mRNA-based COVID-19 vaccines from Pfizer/BioNTech and Moderna, cardiologists have come ou
Indian digital health company Qure.ai is making an artificial intelligence-driven diagnostic app available to doctors scrambling to cope with escalating COVID-19 cases and deaths.<
People who have received two doses of the AstraZeneca or Pfizer/BioNTech COVID-19 vaccines have good protection against the Indian variant of SARS-CoV-2 , according to new UK data.